{
    "nct_id": "NCT02337907",
    "title": "A Multi-centre, Double-blind, Parallel-group, Randomised Controlled Study to Investigate Efficacy, Safety and Tolerability of Orally Administered BI 409306 During a 12-week Treatment Period Compared to Placebo in Patients With Cognitive Impairment Due to Alzheimer's Disease",
    "status": "COMPLETED",
    "last_update_time": "2018-10-18",
    "description_brief": "The study is designed to compare the effects of BI 409306 compared to placebo in patients with cognitive impairment due to Alzheimer's Disease",
    "description_detailed": "N/A",
    "phase": [
        "PHASE2"
    ],
    "study_type": "INTERVENTIONAL",
    "primary_purpose": "TREATMENT",
    "results": {
        "participantFlowModule": {
            "preAssignmentDetails": "All patients were screened for eligibility. All patients eligible after screening underwent a 2-week single-blind placebo run-in period before randomisation. Patients were not to be randomized to trial treatment if any one of the specific entry criteria were not met.",
            "recruitmentDetails": "This was a Phase II, multi-centre, double-blind, parallel-group, randomised, placebo controlled trial with patients with mild Alzheimer's disease. The randomisation allocation ratio was 1:1:1:1:2 of 10 milligram (mg), 25 mg, 50 mg once daily (QD), 25 mg twice a day (BID) of BI 409306 and placebo respectively.",
            "groups": [
                {
                    "id": "FG000",
                    "title": "BI 409306 10 Milligram (mg) Once Daily (QD)",
                    "description": "Patients were administered orally a tablet of 10 mg BI 409306 once daily for 12 weeks."
                },
                {
                    "id": "FG001",
                    "title": "BI 409306 25 mg QD",
                    "description": "Patients were administered orally a tablet of 25 mg BI 409306 once daily for 12 weeks."
                },
                {
                    "id": "FG002",
                    "title": "BI 409306 50 mg QD",
                    "description": "Patients were administered orally a tablet of 50 mg BI 409306 once daily for 12 weeks."
                },
                {
                    "id": "FG003",
                    "title": "BI 409306 25 mg Twice Daily (BID)",
                    "description": "Patients were administered orally a tablet of 25 mg BI 409306 twice daily for 12 weeks."
                },
                {
                    "id": "FG004",
                    "title": "Placebo Matching BI 409306",
                    "description": "Patients were administered orally tablet of Placebo matching BI 409306 once daily for 12 weeks."
                },
                {
                    "id": "FG005",
                    "title": "Donepezil QD",
                    "description": "Patients were administered orally over capsulated tablet of Donepezil once daily for 12 weeks."
                }
            ],
            "periods": [
                {
                    "title": "Overall Study",
                    "milestones": [
                        {
                            "type": "STARTED",
                            "achievements": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "55"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "53"
                                },
                                {
                                    "groupId": "FG002",
                                    "numSubjects": "55"
                                },
                                {
                                    "groupId": "FG003",
                                    "numSubjects": "55"
                                },
                                {
                                    "groupId": "FG004",
                                    "numSubjects": "106"
                                },
                                {
                                    "groupId": "FG005",
                                    "numSubjects": "5"
                                }
                            ]
                        },
                        {
                            "type": "COMPLETED",
                            "achievements": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "51"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "49"
                                },
                                {
                                    "groupId": "FG002",
                                    "numSubjects": "54"
                                },
                                {
                                    "groupId": "FG003",
                                    "numSubjects": "51"
                                },
                                {
                                    "groupId": "FG004",
                                    "numSubjects": "96"
                                },
                                {
                                    "groupId": "FG005",
                                    "numSubjects": "4"
                                }
                            ]
                        },
                        {
                            "type": "NOT COMPLETED",
                            "achievements": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "4"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "4"
                                },
                                {
                                    "groupId": "FG002",
                                    "numSubjects": "1"
                                },
                                {
                                    "groupId": "FG003",
                                    "numSubjects": "4"
                                },
                                {
                                    "groupId": "FG004",
                                    "numSubjects": "10"
                                },
                                {
                                    "groupId": "FG005",
                                    "numSubjects": "1"
                                }
                            ]
                        }
                    ],
                    "dropWithdraws": [
                        {
                            "type": "Other than listed",
                            "reasons": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "1"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "0"
                                },
                                {
                                    "groupId": "FG002",
                                    "numSubjects": "0"
                                },
                                {
                                    "groupId": "FG003",
                                    "numSubjects": "1"
                                },
                                {
                                    "groupId": "FG004",
                                    "numSubjects": "1"
                                },
                                {
                                    "groupId": "FG005",
                                    "numSubjects": "0"
                                }
                            ]
                        },
                        {
                            "type": "Withdrawal by Subject",
                            "reasons": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "2"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "3"
                                },
                                {
                                    "groupId": "FG002",
                                    "numSubjects": "0"
                                },
                                {
                                    "groupId": "FG003",
                                    "numSubjects": "2"
                                },
                                {
                                    "groupId": "FG004",
                                    "numSubjects": "5"
                                },
                                {
                                    "groupId": "FG005",
                                    "numSubjects": "0"
                                }
                            ]
                        },
                        {
                            "type": "Lost to Follow-up",
                            "reasons": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "0"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "0"
                                },
                                {
                                    "groupId": "FG002",
                                    "numSubjects": "0"
                                },
                                {
                                    "groupId": "FG003",
                                    "numSubjects": "0"
                                },
                                {
                                    "groupId": "FG004",
                                    "numSubjects": "0"
                                },
                                {
                                    "groupId": "FG005",
                                    "numSubjects": "1"
                                }
                            ]
                        },
                        {
                            "type": "Adverse Event",
                            "reasons": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "1"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "1"
                                },
                                {
                                    "groupId": "FG002",
                                    "numSubjects": "1"
                                },
                                {
                                    "groupId": "FG003",
                                    "numSubjects": "1"
                                },
                                {
                                    "groupId": "FG004",
                                    "numSubjects": "4"
                                },
                                {
                                    "groupId": "FG005",
                                    "numSubjects": "0"
                                }
                            ]
                        }
                    ]
                }
            ]
        },
        "baselineCharacteristicsModule": {
            "populationDescription": "Treated Set (TS) included all patients who were randomised and treated with at least one dose of trial medication.",
            "groups": [
                {
                    "id": "BG000",
                    "title": "BI 409306 10 Milligram (mg) Once Daily (QD)",
                    "description": "Patients were administered orally a tablet of 10 mg BI 409306 once daily for 12 weeks."
                },
                {
                    "id": "BG001",
                    "title": "BI 409306 25 mg QD",
                    "description": "Patients were administered orally a tablet of 25 mg BI 409306 once daily for 12 weeks."
                },
                {
                    "id": "BG002",
                    "title": "BI 409306 50 mg QD",
                    "description": "Patients were administered orally a tablet of 50 mg BI 409306 once daily for 12 weeks."
                },
                {
                    "id": "BG003",
                    "title": "BI 409306 25 mg Twice Daily (BID)",
                    "description": "Patients were administered orally a tablet of 25 mg BI 409306 twice daily for 12 weeks."
                },
                {
                    "id": "BG004",
                    "title": "Placebo Matching BI 409306",
                    "description": "Patients were administered orally tablet of Placebo matching BI 409306 once daily for 12 weeks."
                },
                {
                    "id": "BG005",
                    "title": "Donepezil QD",
                    "description": "Patients were administered orally over capsulated tablet of Donepezil once daily for 12 weeks."
                },
                {
                    "id": "BG006",
                    "title": "Total",
                    "description": "Total of all reporting groups"
                }
            ],
            "denoms": [
                {
                    "units": "Participants",
                    "counts": [
                        {
                            "groupId": "BG000",
                            "value": "55"
                        },
                        {
                            "groupId": "BG001",
                            "value": "53"
                        },
                        {
                            "groupId": "BG002",
                            "value": "55"
                        },
                        {
                            "groupId": "BG003",
                            "value": "55"
                        },
                        {
                            "groupId": "BG004",
                            "value": "106"
                        },
                        {
                            "groupId": "BG005",
                            "value": "5"
                        },
                        {
                            "groupId": "BG006",
                            "value": "329"
                        }
                    ]
                }
            ],
            "measures": [
                {
                    "title": "Age, Continuous",
                    "description": "Age at the time of signing informed consent form is presented.",
                    "paramType": "MEAN",
                    "dispersionType": "STANDARD_DEVIATION",
                    "unitOfMeasure": "Years",
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "73.7",
                                            "spread": "8.4"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "74.2",
                                            "spread": "7.8"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "73.0",
                                            "spread": "6.5"
                                        },
                                        {
                                            "groupId": "BG003",
                                            "value": "74.8",
                                            "spread": "9.1"
                                        },
                                        {
                                            "groupId": "BG004",
                                            "value": "74.0",
                                            "spread": "7.7"
                                        },
                                        {
                                            "groupId": "BG005",
                                            "value": "79.6",
                                            "spread": "7.0"
                                        },
                                        {
                                            "groupId": "BG006",
                                            "value": "74.0",
                                            "spread": "7.9"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "title": "Sex: Female, Male",
                    "description": "Number of subjects is categorized as Male or Female.",
                    "paramType": "COUNT_OF_PARTICIPANTS",
                    "unitOfMeasure": "Participants",
                    "classes": [
                        {
                            "categories": [
                                {
                                    "title": "Female",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "26"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "30"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "26"
                                        },
                                        {
                                            "groupId": "BG003",
                                            "value": "30"
                                        },
                                        {
                                            "groupId": "BG004",
                                            "value": "48"
                                        },
                                        {
                                            "groupId": "BG005",
                                            "value": "3"
                                        },
                                        {
                                            "groupId": "BG006",
                                            "value": "163"
                                        }
                                    ]
                                },
                                {
                                    "title": "Male",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "29"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "23"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "29"
                                        },
                                        {
                                            "groupId": "BG003",
                                            "value": "25"
                                        },
                                        {
                                            "groupId": "BG004",
                                            "value": "58"
                                        },
                                        {
                                            "groupId": "BG005",
                                            "value": "2"
                                        },
                                        {
                                            "groupId": "BG006",
                                            "value": "166"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "title": "Ethnicity (NIH/OMB)",
                    "description": "Number of subjects is categorized for ethnicity data.",
                    "paramType": "COUNT_OF_PARTICIPANTS",
                    "unitOfMeasure": "Participants",
                    "classes": [
                        {
                            "categories": [
                                {
                                    "title": "Hispanic or Latino",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "2"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "2"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "4"
                                        },
                                        {
                                            "groupId": "BG003",
                                            "value": "2"
                                        },
                                        {
                                            "groupId": "BG004",
                                            "value": "2"
                                        },
                                        {
                                            "groupId": "BG005",
                                            "value": "1"
                                        },
                                        {
                                            "groupId": "BG006",
                                            "value": "13"
                                        }
                                    ]
                                },
                                {
                                    "title": "Not Hispanic or Latino",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "53"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "51"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "51"
                                        },
                                        {
                                            "groupId": "BG003",
                                            "value": "53"
                                        },
                                        {
                                            "groupId": "BG004",
                                            "value": "104"
                                        },
                                        {
                                            "groupId": "BG005",
                                            "value": "4"
                                        },
                                        {
                                            "groupId": "BG006",
                                            "value": "316"
                                        }
                                    ]
                                },
                                {
                                    "title": "Unknown or Not Reported",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG003",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG004",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG005",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG006",
                                            "value": "0"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "title": "Race (NIH/OMB)",
                    "description": "Number of subjects is categorized for race data.",
                    "paramType": "COUNT_OF_PARTICIPANTS",
                    "unitOfMeasure": "Participants",
                    "classes": [
                        {
                            "categories": [
                                {
                                    "title": "American Indian or Alaska Native",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG003",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG004",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG005",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG006",
                                            "value": "0"
                                        }
                                    ]
                                },
                                {
                                    "title": "Asian",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "1"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "1"
                                        },
                                        {
                                            "groupId": "BG003",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG004",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG005",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG006",
                                            "value": "2"
                                        }
                                    ]
                                },
                                {
                                    "title": "Native Hawaiian or Other Pacific Islander",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG003",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG004",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG005",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG006",
                                            "value": "0"
                                        }
                                    ]
                                },
                                {
                                    "title": "Black or African American",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG003",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG004",
                                            "value": "3"
                                        },
                                        {
                                            "groupId": "BG005",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG006",
                                            "value": "3"
                                        }
                                    ]
                                },
                                {
                                    "title": "White",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "54"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "53"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "54"
                                        },
                                        {
                                            "groupId": "BG003",
                                            "value": "55"
                                        },
                                        {
                                            "groupId": "BG004",
                                            "value": "103"
                                        },
                                        {
                                            "groupId": "BG005",
                                            "value": "5"
                                        },
                                        {
                                            "groupId": "BG006",
                                            "value": "324"
                                        }
                                    ]
                                },
                                {
                                    "title": "More than one race",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG003",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG004",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG005",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG006",
                                            "value": "0"
                                        }
                                    ]
                                },
                                {
                                    "title": "Unknown or Not Reported",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG003",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG004",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG005",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG006",
                                            "value": "0"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                }
            ]
        },
        "outcomeMeasuresModule": {
            "outcomeMeasures": [
                {
                    "type": "PRIMARY",
                    "title": "Change From Baseline in Neuropsychological Test Battery in Total Z-score After 12-week Treatment.",
                    "description": "Neuropsychological Test Battery (NTB) response, defined as change from baseline in total z-score after 12 weeks of treatment. The NTB consists of 9 validated components. Raw scores on each of the 9 NTB tests were converted to z-scores using the baseline means and standard deviations (SDs) for each test. The resultant z-scores were averaged to obtain a total z-score, incorporating all 9 NTB tests. The NTB Z-score indicates the number of standard deviations away from the mean. A Z-score of 0 is equal to the mean at baseline. Negative numbers indicate values lower than baseline and positive numbers indicate values higher than baseline. Least Squares Mean is actually an adjusted mean change from baseline.",
                    "populationDescription": "The full analysis set (FAS): FAS includes all randomised patients who were treated with at least one dose of trial medication and had a baseline and at least one post-baseline on-treatment primary endpoint NTB or secondary endpoint assessment. Observed cases (OC)",
                    "reportingStatus": "POSTED",
                    "paramType": "LEAST_SQUARES_MEAN",
                    "dispersionType": "Standard Error",
                    "unitOfMeasure": "Z-score",
                    "timeFrame": "Baseline and 12 weeks",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "BI 409306 10 Milligram (mg) Once Daily (QD)",
                            "description": "Patients were administered orally a tablet of 10 mg BI 409306 once daily for 12 weeks."
                        },
                        {
                            "id": "OG001",
                            "title": "BI 409306 25 mg QD",
                            "description": "Patients were administered orally a tablet of 25 mg BI 409306 once daily for 12 weeks."
                        },
                        {
                            "id": "OG002",
                            "title": "BI 409306 50 mg QD",
                            "description": "Patients were administered orally a tablet of 50 mg BI 409306 once daily for 12 weeks."
                        },
                        {
                            "id": "OG003",
                            "title": "BI 409306 25 mg Twice Daily (BID)",
                            "description": "Patients were administered orally a tablet of 25 mg BI 409306 twice daily for 12 weeks."
                        },
                        {
                            "id": "OG004",
                            "title": "Pooled BI 409306",
                            "description": "Patients were administered orally a tablet of BI 409306 (10 mg, 25 mg, 50 mg once daily and 25 mg twice daily)for 12 weeks."
                        },
                        {
                            "id": "OG005",
                            "title": "Placebo Matching BI 409306",
                            "description": "Patients were administered orally tablet of Placebo matching BI 409306 once daily for 12 weeks."
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "54"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "50"
                                },
                                {
                                    "groupId": "OG002",
                                    "value": "55"
                                },
                                {
                                    "groupId": "OG003",
                                    "value": "55"
                                },
                                {
                                    "groupId": "OG004",
                                    "value": "214"
                                },
                                {
                                    "groupId": "OG005",
                                    "value": "101"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "0.13",
                                            "spread": "0.059"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "0.17",
                                            "spread": "0.061"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "0.16",
                                            "spread": "0.056"
                                        },
                                        {
                                            "groupId": "OG003",
                                            "value": "0.01",
                                            "spread": "0.060"
                                        },
                                        {
                                            "groupId": "OG004",
                                            "value": "0.12",
                                            "spread": "0.30"
                                        },
                                        {
                                            "groupId": "OG005",
                                            "value": "0.15",
                                            "spread": "0.045"
                                        }
                                    ]
                                }
                            ]
                        }
                    ],
                    "analyses": [
                        {
                            "groupIds": [
                                "OG000",
                                "OG005"
                            ],
                            "groupDescription": "Mixed Model Repeated Measurement (MMRM) includes fixed, categorical effects of treatment, visit, current Acetylcholine Esterase Inhibitor (AChEI) use (Yes, No), and treatment-by-visit interaction, as well as the continuous fixed covariates of baseline, and baseline-by-visit interaction.",
                            "nonInferiorityType": "SUPERIORITY",
                            "nonInferiorityComment": "H0: The dose group with the peak response in the respective model Mean NTB response = Mean NTB response of placebo.",
                            "pValue": "0.7907",
                            "pValueComment": "p-value was nominal and not adjusted.",
                            "statisticalMethod": "Mixed Model Repeated Measurement (MMRM)",
                            "statisticalComment": "Kenward-Roger was used to model degrees of freedom.",
                            "paramType": "Mean Difference (Final Values)",
                            "paramValue": "-0.02",
                            "ciPctValue": "95",
                            "ciNumSides": "TWO_SIDED",
                            "ciLowerLimit": "-0.163",
                            "ciUpperLimit": "0.124",
                            "dispersionType": "STANDARD_ERROR_OF_MEAN",
                            "dispersionValue": "0.073",
                            "estimateComment": "The mean difference is actually adjusted mean of difference and the dispersion value is standard error of differences."
                        },
                        {
                            "groupIds": [
                                "OG001",
                                "OG005"
                            ],
                            "groupDescription": "Mixed Model Repeated Measurement (MMRM) includes fixed, categorical effects of treatment, visit, current Acetylcholine Esterase Inhibitor (AChEI) use (Yes, No), and treatment-by-visit interaction, as well as the continuous fixed covariates of baseline, and baseline-by-visit interaction.",
                            "nonInferiorityType": "SUPERIORITY",
                            "nonInferiorityComment": "H0: The dose group with the peak response in the respective model Mean NTB response = Mean NTB response of placebo.",
                            "pValue": "0.7622",
                            "pValueComment": "p-value was nominal and not adjusted.",
                            "statisticalMethod": "Mixed Model Repeated Measurement (MMRM)",
                            "statisticalComment": "Kenward-Roger was used to model degrees of freedom.",
                            "paramType": "Mean Difference (Final Values)",
                            "paramValue": "0.02",
                            "ciPctValue": "95",
                            "ciNumSides": "TWO_SIDED",
                            "ciLowerLimit": "-0.125",
                            "ciUpperLimit": "0.171",
                            "dispersionType": "STANDARD_ERROR_OF_MEAN",
                            "dispersionValue": "0.075",
                            "estimateComment": "The mean difference is actually adjusted mean of difference and the dispersion value is standard error of differences."
                        },
                        {
                            "groupIds": [
                                "OG002",
                                "OG005"
                            ],
                            "groupDescription": "Mixed Model Repeated Measurement (MMRM) includes fixed, categorical effects of treatment, visit, current Acetylcholine Esterase Inhibitor (AChEI) use (Yes, No), and treatment-by-visit interaction, as well as the continuous fixed covariates of baseline, and baseline-by-visit interaction.",
                            "nonInferiorityType": "SUPERIORITY",
                            "nonInferiorityComment": "H0: The dose group with the peak response in the respective model Mean NTB response = Mean NTB response of placebo.",
                            "pValue": "0.8789",
                            "pValueComment": "p-value was nominal and not adjusted.",
                            "statisticalMethod": "Mixed Model Repeated Measurement (MMRM)",
                            "statisticalComment": "Kenward-Roger was used to model degrees of freedom.",
                            "paramType": "Mean Difference (Net)",
                            "paramValue": "0.01",
                            "ciPctValue": "95",
                            "ciNumSides": "TWO_SIDED",
                            "ciLowerLimit": "-0.130",
                            "ciUpperLimit": "0.152",
                            "dispersionType": "STANDARD_ERROR_OF_MEAN",
                            "dispersionValue": "0.071",
                            "estimateComment": "The mean difference is actually adjusted mean of difference and the dispersion value is standard error of differences."
                        },
                        {
                            "groupIds": [
                                "OG003",
                                "OG005"
                            ],
                            "groupDescription": "Mixed Model Repeated Measurement (MMRM) includes fixed, categorical effects of treatment, visit, current Acetylcholine Esterase Inhibitor (AChEI) use (Yes, No), and treatment-by-visit interaction, as well as the continuous fixed covariates of baseline, and baseline-by-visit interaction.",
                            "nonInferiorityType": "SUPERIORITY",
                            "nonInferiorityComment": "H0: The dose group with the peak response in the respective model Mean NTB response = Mean NTB response of placebo.",
                            "pValue": "0.0609",
                            "pValueComment": "p-value was nominal and not adjusted.",
                            "statisticalMethod": "Mixed Model Repeated Measurement (MMRM)",
                            "statisticalComment": "Kenward-Roger was used to model degrees of freedom.",
                            "paramType": "Mean Difference (Final Values)",
                            "paramValue": "-0.14",
                            "ciPctValue": "95",
                            "ciNumSides": "TWO_SIDED",
                            "ciLowerLimit": "-0.285",
                            "ciUpperLimit": "0.006",
                            "dispersionType": "STANDARD_ERROR_OF_MEAN",
                            "dispersionValue": "0.074",
                            "estimateComment": "The mean difference is actually adjusted mean of difference and the dispersion value is standard error of differences"
                        },
                        {
                            "groupIds": [
                                "OG004",
                                "OG005"
                            ],
                            "groupDescription": "Mixed Model Repeated Measurement (MMRM) includes fixed, categorical effects of treatment, visit, current Acetylcholine Esterase Inhibitor (AChEI) use (Yes, No), and treatment-by-visit interaction, as well as the continuous fixed covariates of baseline, and baseline-by-visit interaction.",
                            "nonInferiorityType": "SUPERIORITY",
                            "nonInferiorityComment": "H1-0: Mean NTB response of pooled doses of 10 mg QD, 25 mg QD, 25 mg BID and 50 mg QD = Mean NTB response of placebo",
                            "pValue": "0.5687",
                            "pValueComment": "p-value was nominal and not adjusted.",
                            "statisticalMethod": "Mixed Model Repeated Measurement (MMRM)",
                            "statisticalComment": "Kenward-Roger was used to model degrees of freedom.",
                            "paramType": "Mean Difference (Final Values)",
                            "paramValue": "-0.03",
                            "ciPctValue": "95",
                            "ciNumSides": "TWO_SIDED",
                            "ciLowerLimit": "-0.135",
                            "ciUpperLimit": "0.074",
                            "dispersionType": "STANDARD_ERROR_OF_MEAN",
                            "dispersionValue": "0.053",
                            "estimateComment": "The mean difference is actually adjusted mean of difference and the dispersion value is standard error of differences"
                        }
                    ]
                },
                {
                    "type": "PRIMARY",
                    "title": "Change From Baseline in Neuropsychological Test Battery in Total Z-score After 12-week Treatment From Two Sister Trials, Present 1289.5 (NCT02240693) and 1289.7 (NCT02337907)",
                    "description": "Neuropsychological Test Battery (NTB) response, defined as change from baseline in total z-score after 12 weeks of treatment. The NTB consists of 9 validated components. Raw scores on each of the 9 NTB tests were converted to z-scores using the baseline means and standard deviations (SDs) for each test. The resultant z-scores were averaged to obtain a total z-score, incorporating all 9 NTB tests. The NTB Z-score indicates the number of standard deviations away from the mean. A Z-score of 0 is equal to the mean at baseline. Negative numbers indicate values lower than baseline and positive numbers indicate values higher than baseline. The number of low test scores decreased with higher levels of intellectual abilities. Least Squares Mean is actually an adjusted mean change from baseline.",
                    "populationDescription": "FAS (OC) and for pooled group FAS",
                    "reportingStatus": "POSTED",
                    "paramType": "LEAST_SQUARES_MEAN",
                    "dispersionType": "Standard Error",
                    "unitOfMeasure": "Z-score",
                    "timeFrame": "Baseline and 12 weeks",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "BI 409306 10 Milligram (mg) Once Daily (QD)",
                            "description": "Patients were administered orally a tablet of 10 mg BI 409306 once daily for 12 weeks."
                        },
                        {
                            "id": "OG001",
                            "title": "BI 409306 25 mg QD",
                            "description": "Patients were administered orally a tablet of 25 mg BI 409306 once daily for 12 weeks."
                        },
                        {
                            "id": "OG002",
                            "title": "BI 409306 50 mg QD",
                            "description": "Patients were administered orally a tablet of 50 mg BI 409306 once daily for 12 weeks."
                        },
                        {
                            "id": "OG003",
                            "title": "BI 409306 25 mg Twice Daily (BID)",
                            "description": "Patients were administered orally a tablet of 25 mg BI 409306 twice daily for 12 weeks."
                        },
                        {
                            "id": "OG004",
                            "title": "Pooled BI 409306",
                            "description": "Patients were administered orally a tablet of BI 409306 (10 mg, 25 mg, 50 mg once daily and 25 mg twice daily)for 12 weeks."
                        },
                        {
                            "id": "OG005",
                            "title": "Placebo Matching BI 409306",
                            "description": "Patients were administered orally tablet of Placebo matching BI 409306 once daily for 12 weeks."
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "76"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "71"
                                },
                                {
                                    "groupId": "OG002",
                                    "value": "76"
                                },
                                {
                                    "groupId": "OG003",
                                    "value": "76"
                                },
                                {
                                    "groupId": "OG004",
                                    "value": "299"
                                },
                                {
                                    "groupId": "OG005",
                                    "value": "144"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "0.20",
                                            "spread": "0.046"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "0.19",
                                            "spread": "0.048"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "0.19",
                                            "spread": "0.046"
                                        },
                                        {
                                            "groupId": "OG003",
                                            "value": "0.10",
                                            "spread": "0.047"
                                        },
                                        {
                                            "groupId": "OG004",
                                            "value": "0.17",
                                            "spread": "0.025"
                                        },
                                        {
                                            "groupId": "OG005",
                                            "value": "0.19",
                                            "spread": "0.035"
                                        }
                                    ]
                                }
                            ]
                        }
                    ],
                    "analyses": [
                        {
                            "groupIds": [
                                "OG000",
                                "OG005"
                            ],
                            "groupDescription": "Mixed Model Repeated Measurement (MMRM) includes fixed, categorical effects of treatment, visit, current Acetylcholine Esterase Inhibitor (AChEI) use (Yes, No), and treatment-by-visit interaction, as well as the continuous fixed covariates of baseline, and baseline-by-visit interaction. The study identifier is also a categorical covariate for the twin studies analyses.",
                            "nonInferiorityType": "SUPERIORITY",
                            "nonInferiorityComment": "H0: The dose group with the peak response in the respective model Mean NTB response = Mean NTB response of placebo.",
                            "pValue": "0.8694",
                            "pValueComment": "p-value was nominal and not adjusted.",
                            "statisticalMethod": "Mixed Model Repeated Measurement (MMRM)",
                            "statisticalComment": "Kenward-Roger was used to model degrees of freedom.",
                            "paramType": "Mean Difference (Final Values)",
                            "paramValue": "0.01",
                            "ciPctValue": "95",
                            "ciNumSides": "TWO_SIDED",
                            "ciLowerLimit": "-0.101",
                            "ciUpperLimit": "0.120",
                            "dispersionType": "STANDARD_ERROR_OF_MEAN",
                            "dispersionValue": "0.056",
                            "estimateComment": "The mean difference is actually adjusted mean of difference and the dispersion value is standard error of differences."
                        },
                        {
                            "groupIds": [
                                "OG001",
                                "OG005"
                            ],
                            "groupDescription": "Mixed Model Repeated Measurement (MMRM) includes fixed, categorical effects of treatment, visit, current Acetylcholine Esterase Inhibitor (AChEI) use (Yes, No), and treatment-by-visit interaction, as well as the continuous fixed covariates of baseline, and baseline-by-visit interaction. The study identifier is also a categorical covariate for the twin studies analyses.",
                            "nonInferiorityType": "SUPERIORITY",
                            "nonInferiorityComment": "H0: The dose group with the peak response in the respective model Mean NTB response = Mean NTB response of placebo.",
                            "pValue": "0.9512",
                            "pValueComment": "p-value was nominal and not adjusted.",
                            "statisticalMethod": "Mixed Model Repeated Measurement (MMRM)",
                            "statisticalComment": "Kenward-Roger was used to model degrees of freedom.",
                            "paramType": "Mean Difference (Final Values)",
                            "paramValue": "0.00",
                            "ciPctValue": "95",
                            "ciNumSides": "TWO_SIDED",
                            "ciLowerLimit": "-0.116",
                            "ciUpperLimit": "0.109",
                            "dispersionType": "STANDARD_ERROR_OF_MEAN",
                            "dispersionValue": "0.057",
                            "estimateComment": "The mean difference is actually adjusted mean of difference and the dispersion value is standard error of differences."
                        },
                        {
                            "groupIds": [
                                "OG002",
                                "OG005"
                            ],
                            "groupDescription": "Mixed Model Repeated Measurement (MMRM) includes fixed, categorical effects of treatment, visit, current Acetylcholine Esterase Inhibitor (AChEI) use (Yes, No), and treatment-by-visit interaction, as well as the continuous fixed covariates of baseline, and baseline-by-visit interaction. The study identifier is also a categorical covariate for the twin studies analyses.",
                            "nonInferiorityType": "SUPERIORITY",
                            "nonInferiorityComment": "H0: The dose group with the peak response in the respective model Mean NTB response = Mean NTB response of placebo.",
                            "pValue": "0.9321",
                            "pValueComment": "p-value was nominal and not adjusted.",
                            "statisticalMethod": "Mixed Model Repeated Measurement (MMRM)",
                            "statisticalComment": "Kenward-Roger was used to model degrees of freedom.",
                            "paramType": "Mean Difference (Net)",
                            "paramValue": "0.00",
                            "ciPctValue": "95",
                            "ciNumSides": "TWO_SIDED",
                            "ciLowerLimit": "-0.105",
                            "ciUpperLimit": "0.115",
                            "dispersionType": "STANDARD_ERROR_OF_MEAN",
                            "dispersionValue": "0.056",
                            "estimateComment": "The mean difference is actually adjusted mean of difference and the dispersion value is standard error of differences."
                        },
                        {
                            "groupIds": [
                                "OG003",
                                "OG005"
                            ],
                            "groupDescription": "Mixed Model Repeated Measurement (MMRM) includes fixed, categorical effects of treatment, visit, current Acetylcholine Esterase Inhibitor (AChEI) use (Yes, No), and treatment-by-visit interaction, as well as the continuous fixed covariates of baseline, and baseline-by-visit interaction. The study identifier is also a categorical covariate for the twin studies analyses.",
                            "nonInferiorityType": "SUPERIORITY",
                            "nonInferiorityComment": "H0: The dose group with the peak response in the respective model Mean NTB response = Mean NTB response of placebo.",
                            "pValue": "0.1288",
                            "pValueComment": "p-value was nominal and not adjusted.",
                            "statisticalMethod": "Mixed Model Repeated Measurement (MMRM)",
                            "statisticalComment": "Kenward-Roger was used to model degrees of freedom.",
                            "paramType": "Mean Difference (Final Values)",
                            "paramValue": "-0.09",
                            "ciPctValue": "95",
                            "ciNumSides": "TWO_SIDED",
                            "ciLowerLimit": "-0.199",
                            "ciUpperLimit": "0.025",
                            "dispersionType": "STANDARD_ERROR_OF_MEAN",
                            "dispersionValue": "0.057",
                            "estimateComment": "The mean difference is actually adjusted mean of difference and the dispersion value is standard error of differences"
                        },
                        {
                            "groupIds": [
                                "OG004",
                                "OG005"
                            ],
                            "groupDescription": "Mixed Model Repeated Measurement (MMRM) includes fixed, categorical effects of treatment, visit, current Acetylcholine Esterase Inhibitor (AChEI) use (Yes, No), and treatment-by-visit interaction, as well as the continuous fixed covariates of baseline, and baseline-by-visit interaction. The study identifier is also a categorical covariate for the twin studies analyses.",
                            "nonInferiorityType": "SUPERIORITY",
                            "nonInferiorityComment": "H1-0: Mean NTB response of pooled doses of 10 mg QD, 25 mg QD, 25 mg BID and 50 mg QD = Mean NTB response of placebo.",
                            "pValue": "0.6492",
                            "pValueComment": "p-value was nominal and not adjusted.",
                            "statisticalMethod": "Mixed Model Repeated Measurement (MMRM)",
                            "statisticalComment": "Kenward-Roger was used to model degrees of freedom.",
                            "paramType": "Mean Difference (Final Values)",
                            "paramValue": "-0.02",
                            "ciPctValue": "95",
                            "ciNumSides": "TWO_SIDED",
                            "ciLowerLimit": "-0.098",
                            "ciUpperLimit": "0.061",
                            "dispersionType": "STANDARD_ERROR_OF_MEAN",
                            "dispersionValue": "0.041",
                            "estimateComment": "The mean difference is actually adjusted mean of difference and the dispersion value is standard error of differences"
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Change From Baseline in Alzheimer's Disease Cooperative Study/Activities of Daily Living (ADCS-ADL) Total Score After 12-week Treatment",
                    "description": "Alzheimer's Disease Cooperative Study/Activities of Daily Living (ADCS-ADL) is a rating scale used to assess basic and instrumental activities of daily living. In the full version of the scale, 23 items are rated by the investigator using information supplied by the caregiver. Each item has a score range varying from 0-3 to 0-5. The sum score can range from 0 to 78. Higher scores indicate better function. Least Squares Mean is actually an adjusted mean change from baseline.",
                    "populationDescription": "FAS",
                    "reportingStatus": "POSTED",
                    "paramType": "LEAST_SQUARES_MEAN",
                    "dispersionType": "Standard Error",
                    "unitOfMeasure": "Unit on scale",
                    "timeFrame": "Baseline and 12 weeks",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "BI 409306 10 Milligram (mg) Once Daily (QD)",
                            "description": "Patients were administered orally a tablet of 10 mg BI 409306 once daily for 12 weeks."
                        },
                        {
                            "id": "OG001",
                            "title": "BI 409306 25 mg QD",
                            "description": "Patients were administered orally a tablet of 25 mg BI 409306 once daily for 12 weeks."
                        },
                        {
                            "id": "OG002",
                            "title": "BI 409306 50 mg QD",
                            "description": "Patients were administered orally a tablet of 50 mg BI 409306 once daily for 12 weeks."
                        },
                        {
                            "id": "OG003",
                            "title": "BI 409306 25 mg Twice Daily (BID)",
                            "description": "Patients were administered orally a tablet of 25 mg BI 409306 twice daily for 12 weeks."
                        },
                        {
                            "id": "OG004",
                            "title": "Placebo Matching BI 409306",
                            "description": "Patients were administered orally tablet of Placebo matching BI 409306 once daily for 12 weeks."
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "54"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "50"
                                },
                                {
                                    "groupId": "OG002",
                                    "value": "55"
                                },
                                {
                                    "groupId": "OG003",
                                    "value": "55"
                                },
                                {
                                    "groupId": "OG004",
                                    "value": "101"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "0.10",
                                            "spread": "0.853"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "-0.99",
                                            "spread": "0.892"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "0.35",
                                            "spread": "0.847"
                                        },
                                        {
                                            "groupId": "OG003",
                                            "value": "-1.07",
                                            "spread": "0.855"
                                        },
                                        {
                                            "groupId": "OG004",
                                            "value": "-0.58",
                                            "spread": "0.639"
                                        }
                                    ]
                                }
                            ]
                        }
                    ],
                    "analyses": [
                        {
                            "groupIds": [
                                "OG000",
                                "OG004"
                            ],
                            "groupDescription": "The dependent variable was the change from the baseline score at Week 12. The model included fixed, categorical covariates of treatment as well as fixed continuous covariates of baseline score.",
                            "nonInferiorityType": "SUPERIORITY",
                            "nonInferiorityComment": "Analyses of covariance (ANCOVA) were used to assess between-group differences in the modelled changes from baseline to Week 12.",
                            "pValue": "0.5287",
                            "pValueComment": "p-value was nominal and not adjusted.",
                            "statisticalMethod": "ANCOVA",
                            "paramType": "Mean Difference (Final Values)",
                            "paramValue": "0.67",
                            "ciPctValue": "95",
                            "ciNumSides": "TWO_SIDED",
                            "ciLowerLimit": "-1.43",
                            "ciUpperLimit": "2.77",
                            "dispersionType": "STANDARD_ERROR_OF_MEAN",
                            "dispersionValue": "1.066",
                            "estimateComment": "The mean difference is actually adjusted mean of difference and the dispersion value is standard error of differences."
                        },
                        {
                            "groupIds": [
                                "OG001",
                                "OG004"
                            ],
                            "groupDescription": "The dependent variable was the change from the baseline score at Week 12. The model included fixed, categorical covariates of treatment as well as fixed continuous covariates of baseline score.",
                            "nonInferiorityType": "SUPERIORITY",
                            "nonInferiorityComment": "Analyses of covariance (ANCOVA) were used to assess between-group differences in the modelled changes from baseline to Week 12.",
                            "pValue": "0.7105",
                            "pValueComment": "p-value was nominal and not adjusted.",
                            "statisticalMethod": "ANCOVA",
                            "paramType": "Mean Difference (Final Values)",
                            "paramValue": "-0.41",
                            "ciPctValue": "95",
                            "ciNumSides": "TWO_SIDED",
                            "ciLowerLimit": "-2.57",
                            "ciUpperLimit": "1.76",
                            "dispersionType": "STANDARD_ERROR_OF_MEAN",
                            "dispersionValue": "1.099",
                            "estimateComment": "The mean difference is actually adjusted mean of difference and the dispersion value is standard error of differences."
                        },
                        {
                            "groupIds": [
                                "OG002",
                                "OG004"
                            ],
                            "groupDescription": "The dependent variable was the change from the baseline score at Week 12. The model included fixed, categorical covariates of treatment as well as fixed continuous covariates of baseline score.",
                            "nonInferiorityType": "SUPERIORITY",
                            "nonInferiorityComment": "Analyses of covariance (ANCOVA) were used to assess between-group differences in the modelled changes from baseline to Week 12.",
                            "pValue": "0.3822",
                            "pValueComment": "p-value was nominal and not adjusted.",
                            "statisticalMethod": "ANCOVA",
                            "paramType": "Mean Difference (Final Values)",
                            "paramValue": "0.93",
                            "ciPctValue": "95",
                            "ciNumSides": "TWO_SIDED",
                            "ciLowerLimit": "-1.16",
                            "ciUpperLimit": "3.03",
                            "dispersionType": "STANDARD_ERROR_OF_MEAN",
                            "dispersionValue": "1.064",
                            "estimateComment": "The mean difference is actually adjusted mean of difference and the dispersion value is standard error of differences."
                        },
                        {
                            "groupIds": [
                                "OG003",
                                "OG004"
                            ],
                            "groupDescription": "The dependent variable was the change from the baseline score at Week 12. The model included fixed, categorical covariates of treatment as well as fixed continuous covariates of baseline score.",
                            "nonInferiorityType": "SUPERIORITY",
                            "nonInferiorityComment": "Analyses of covariance (ANCOVA) were used to assess between-group differences in the modelled changes from baseline to Week 12.",
                            "pValue": "0.6472",
                            "pValueComment": "p-value was nominal and not adjusted.",
                            "statisticalMethod": "ANCOVA",
                            "paramType": "Mean Difference (Final Values)",
                            "paramValue": "-0.49",
                            "ciPctValue": "95",
                            "ciNumSides": "TWO_SIDED",
                            "ciLowerLimit": "-2.59",
                            "ciUpperLimit": "1.61",
                            "dispersionType": "STANDARD_ERROR_OF_MEAN",
                            "dispersionValue": "1.066",
                            "estimateComment": "The mean difference is actually adjusted mean of difference and the dispersion value is standard error of differences."
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Change From Baseline in Clinical Dementia Rating Scale Sum of Boxes (CDR-SB) Total Score After 12-week Treatment",
                    "description": "The CDR-SB is obtained through semi-structured interviews of patients and informants, and cognitive functioning was rated in 6 domains of functioning: memory, orientation, judgment and problem solving, community affairs, home and hobbies and personal care. Each domain was rated on a 5-point scale of functioning as follows: 0-no impairment; 0.5-questionable impairment; 1-mild impairment; 2-moderate impairment and 3-severe impairment. Only personal care was scored on a 4-point scale without a 0.5 rating available. The higher the score, the greater the severity of dementia. Least Squares Mean is actually an adjusted mean change from baseline.",
                    "populationDescription": "FAS",
                    "reportingStatus": "POSTED",
                    "paramType": "LEAST_SQUARES_MEAN",
                    "dispersionType": "Standard Error",
                    "unitOfMeasure": "Unit on scale",
                    "timeFrame": "Baseline and 12 weeks",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "BI 409306 10 Milligram (mg) Once Daily (QD)",
                            "description": "Patients were administered orally a tablet of 10 mg BI 409306 once daily for 12 weeks."
                        },
                        {
                            "id": "OG001",
                            "title": "BI 409306 25 mg QD",
                            "description": "Patients were administered orally a tablet of 25 mg BI 409306 once daily for 12 weeks."
                        },
                        {
                            "id": "OG002",
                            "title": "BI 409306 50 mg QD",
                            "description": "Patients were administered orally a tablet of 50 mg BI 409306 once daily for 12 weeks."
                        },
                        {
                            "id": "OG003",
                            "title": "BI 409306 25 mg Twice Daily (BID)",
                            "description": "Patients were administered orally a tablet of 25 mg BI 409306 twice daily for 12 weeks."
                        },
                        {
                            "id": "OG004",
                            "title": "Placebo Matching BI 409306",
                            "description": "Patients were administered orally tablet of Placebo matching BI 409306 once daily for 12 weeks."
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "54"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "50"
                                },
                                {
                                    "groupId": "OG002",
                                    "value": "55"
                                },
                                {
                                    "groupId": "OG003",
                                    "value": "55"
                                },
                                {
                                    "groupId": "OG004",
                                    "value": "101"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "0.1",
                                            "spread": "0.23"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "0.3",
                                            "spread": "0.23"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "0.1",
                                            "spread": "0.21"
                                        },
                                        {
                                            "groupId": "OG003",
                                            "value": "0.2",
                                            "spread": "0.22"
                                        },
                                        {
                                            "groupId": "OG004",
                                            "value": "0.1",
                                            "spread": "0.16"
                                        }
                                    ]
                                }
                            ]
                        }
                    ],
                    "analyses": [
                        {
                            "groupIds": [
                                "OG000",
                                "OG004"
                            ],
                            "groupDescription": "Mixed Model Repeated Measurement (MMRM) includes fixed, categorical effects of treatment, visit, current Acetylcholine Esterase Inhibitor (AChEI) use (Yes, No), and treatment-by-visit interaction, as well as the continuous fixed covariates of baseline, and baseline-by-visit interaction.",
                            "nonInferiorityType": "SUPERIORITY",
                            "pValue": "0.7551",
                            "pValueComment": "p-value was nominal and not adjusted.",
                            "statisticalMethod": "Mixed-effects Model for Repeated Measure",
                            "statisticalComment": "Kenward-Roger was used to model degrees of freedom.",
                            "paramType": "Mean Difference (Final Values)",
                            "paramValue": "0.1",
                            "ciPctValue": "95",
                            "ciNumSides": "TWO_SIDED",
                            "ciLowerLimit": "-0.46",
                            "ciUpperLimit": "0.64",
                            "dispersionType": "STANDARD_ERROR_OF_MEAN",
                            "dispersionValue": "0.28",
                            "estimateComment": "The mean difference is actually adjusted mean of difference and the dispersion value is standard error of differences."
                        },
                        {
                            "groupIds": [
                                "OG001",
                                "OG004"
                            ],
                            "groupDescription": "Mixed Model Repeated Measurement (MMRM) includes fixed, categorical effects of treatment, visit, current Acetylcholine Esterase Inhibitor (AChEI) use (Yes, No), and treatment-by-visit interaction, as well as the continuous fixed covariates of baseline, and baseline-by-visit interaction.",
                            "nonInferiorityType": "SUPERIORITY",
                            "pValue": "0.3643",
                            "pValueComment": "p-value was nominal and not adjusted.",
                            "statisticalMethod": "Mixed-effects Model for Repeated Measure",
                            "statisticalComment": "Kenward-Roger was used to model degrees of freedom.",
                            "paramType": "Mean Difference (Final Values)",
                            "paramValue": "0.3",
                            "ciPctValue": "95",
                            "ciNumSides": "TWO_SIDED",
                            "ciLowerLimit": "-0.29",
                            "ciUpperLimit": "0.80",
                            "dispersionType": "STANDARD_ERROR_OF_MEAN",
                            "dispersionValue": "0.28",
                            "estimateComment": "The mean difference is actually adjusted mean of difference and the dispersion value is standard error of differences."
                        },
                        {
                            "groupIds": [
                                "OG002",
                                "OG004"
                            ],
                            "groupDescription": "Mixed Model Repeated Measurement (MMRM) includes fixed, categorical effects of treatment, visit, current Acetylcholine Esterase Inhibitor (AChEI) use (Yes, No), and treatment-by-visit interaction, as well as the continuous fixed covariates of baseline, and baseline-by-visit interaction.",
                            "nonInferiorityType": "SUPERIORITY",
                            "pValue": "0.7822",
                            "pValueComment": "p-value was nominal and not adjusted.",
                            "statisticalMethod": "Mixed-effects Model for Repeated Measure",
                            "statisticalComment": "Kenward-Roger was used to model degrees of freedom.",
                            "paramType": "Mean Difference (Final Values)",
                            "paramValue": "0.1",
                            "ciPctValue": "95",
                            "ciNumSides": "TWO_SIDED",
                            "ciLowerLimit": "-0.45",
                            "ciUpperLimit": "0.60",
                            "dispersionType": "STANDARD_ERROR_OF_MEAN",
                            "dispersionValue": "0.27",
                            "estimateComment": "The mean difference is actually adjusted mean of difference and the dispersion value is standard error of differences."
                        },
                        {
                            "groupIds": [
                                "OG003",
                                "OG004"
                            ],
                            "groupDescription": "Mixed Model Repeated Measurement (MMRM) includes fixed, categorical effects of treatment, visit, current Acetylcholine Esterase Inhibitor (AChEI) use (Yes, No), and treatment-by-visit interaction, as well as the continuous fixed covariates of baseline, and baseline-by-visit interaction.",
                            "nonInferiorityType": "SUPERIORITY",
                            "pValue": "0.6889",
                            "pValueComment": "p-value was nominal and not adjusted.",
                            "statisticalMethod": "Mixed-effects Model for Repeated Measure",
                            "statisticalComment": "Kenward-Roger was used to model degrees of freedom.",
                            "paramType": "Mean Difference (Final Values)",
                            "paramValue": "0.1",
                            "ciPctValue": "95",
                            "ciNumSides": "TWO_SIDED",
                            "ciLowerLimit": "-0.43",
                            "ciUpperLimit": "0.65",
                            "dispersionType": "STANDARD_ERROR_OF_MEAN",
                            "dispersionValue": "0.28",
                            "estimateComment": "The mean difference is actually adjusted mean of difference and the dispersion value is standard error of differences."
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Change From Baseline in Alzheimer's Disease Assessment Scale-cognitive Subscale (ADAS-cog11) Total Score After 12-week Treatment",
                    "description": "Alzheimer's Disease Assessment Scale-cognitive subscale (ADAS-cog11) is an 11-item cognitive subscale that objectively measures memory, language, orientation, and praxis with a total score range of 0 to 70. The greater the dysfunction, the greater the score. Least Squares Mean is actually an adjusted mean change from baseline.",
                    "populationDescription": "FAS",
                    "reportingStatus": "POSTED",
                    "paramType": "LEAST_SQUARES_MEAN",
                    "dispersionType": "Standard Error",
                    "unitOfMeasure": "Unit on scale",
                    "timeFrame": "Baseline and 12 weeks",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "BI 409306 10 Milligram (mg) Once Daily (QD)",
                            "description": "Patients were administered orally a tablet of 10 mg BI 409306 once daily for 12 weeks."
                        },
                        {
                            "id": "OG001",
                            "title": "BI 409306 25 mg QD",
                            "description": "Patients were administered orally a tablet of 25 mg BI 409306 once daily for 12 weeks."
                        },
                        {
                            "id": "OG002",
                            "title": "BI 409306 50 mg QD",
                            "description": "Patients were administered orally a tablet of 50 mg BI 409306 once daily for 12 weeks."
                        },
                        {
                            "id": "OG003",
                            "title": "BI 409306 25 mg Twice Daily (BID)",
                            "description": "Patients were administered orally a tablet of 25 mg BI 409306 twice daily for 12 weeks."
                        },
                        {
                            "id": "OG004",
                            "title": "Placebo Matching BI 409306",
                            "description": "Patients were administered orally tablet of Placebo matching BI 409306 once daily for 12 weeks."
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "54"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "50"
                                },
                                {
                                    "groupId": "OG002",
                                    "value": "55"
                                },
                                {
                                    "groupId": "OG003",
                                    "value": "55"
                                },
                                {
                                    "groupId": "OG004",
                                    "value": "101"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "1.14",
                                            "spread": "0.738"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "0.94",
                                            "spread": "0.776"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "1.11",
                                            "spread": "0.746"
                                        },
                                        {
                                            "groupId": "OG003",
                                            "value": "2.29",
                                            "spread": "0.746"
                                        },
                                        {
                                            "groupId": "OG004",
                                            "value": "-0.18",
                                            "spread": "0.568"
                                        }
                                    ]
                                }
                            ]
                        }
                    ],
                    "analyses": [
                        {
                            "groupIds": [
                                "OG000",
                                "OG004"
                            ],
                            "groupDescription": "The dependent variable was the change from the baseline score at Week 12. The model included fixed, categorical covariates of treatment as well as fixed continuous covariates of baseline score.",
                            "nonInferiorityType": "SUPERIORITY",
                            "nonInferiorityComment": "Analyses of covariance (ANCOVA) were used to assess between-group differences in the modelled changes from baseline to Week 12.",
                            "pValue": "0.1595",
                            "pValueComment": "p-value was nominal and not adjusted.",
                            "statisticalMethod": "ANCOVA",
                            "paramType": "Mean Difference (Final Values)",
                            "paramValue": "1.32",
                            "ciPctValue": "95",
                            "ciNumSides": "TWO_SIDED",
                            "ciLowerLimit": "-0.52",
                            "ciUpperLimit": "3.15",
                            "dispersionType": "STANDARD_ERROR_OF_MEAN",
                            "dispersionValue": "0.933",
                            "estimateComment": "The mean difference is actually adjusted mean of difference and the dispersion value is standard error of differences."
                        },
                        {
                            "groupIds": [
                                "OG001",
                                "OG004"
                            ],
                            "groupDescription": "The dependent variable was the change from the baseline score at Week 12. The model included fixed, categorical covariates of treatment as well as fixed continuous covariates of baseline score.",
                            "nonInferiorityType": "SUPERIORITY",
                            "nonInferiorityComment": "Analyses of covariance (ANCOVA) were used to assess between-group differences in the modelled changes from baseline to Week 12.",
                            "pValue": "0.2455",
                            "pValueComment": "p-value was nominal and not adjusted.",
                            "statisticalMethod": "ANCOVA",
                            "paramType": "Mean Difference (Final Values)",
                            "paramValue": "1.12",
                            "ciPctValue": "95",
                            "ciNumSides": "TWO_SIDED",
                            "ciLowerLimit": "-0.77",
                            "ciUpperLimit": "3.01",
                            "dispersionType": "STANDARD_ERROR_OF_MEAN",
                            "dispersionValue": "0.962",
                            "estimateComment": "The mean difference is actually adjusted mean of difference and the dispersion value is standard error of differences."
                        },
                        {
                            "groupIds": [
                                "OG002",
                                "OG004"
                            ],
                            "groupDescription": "The dependent variable was the change from the baseline score at Week 12. The model included fixed, categorical covariates of treatment as well as fixed continuous covariates of baseline score.",
                            "nonInferiorityType": "SUPERIORITY",
                            "nonInferiorityComment": "Analyses of covariance (ANCOVA) were used to assess between-group differences in the modelled changes from baseline to Week 12.",
                            "pValue": "0.1732",
                            "pValueComment": "p-value was nominal and not adjusted.",
                            "statisticalMethod": "ANCOVA",
                            "paramType": "Mean Difference (Final Values)",
                            "paramValue": "1.28",
                            "ciPctValue": "95",
                            "ciNumSides": "TWO_SIDED",
                            "ciLowerLimit": "-0.57",
                            "ciUpperLimit": "3.13",
                            "dispersionType": "STANDARD_ERROR_OF_MEAN",
                            "dispersionValue": "0.940",
                            "estimateComment": "The mean difference is actually adjusted mean of difference and the dispersion value is standard error of differences."
                        },
                        {
                            "groupIds": [
                                "OG003",
                                "OG004"
                            ],
                            "groupDescription": "The dependent variable was the change from the baseline score at Week 12. The model included fixed, categorical covariates of treatment as well as fixed continuous covariates of baseline score.",
                            "nonInferiorityType": "SUPERIORITY",
                            "nonInferiorityComment": "Analyses of covariance (ANCOVA) were used to assess between-group differences in the modelled changes from baseline to Week 12.",
                            "pValue": "0.0088",
                            "pValueComment": "p-value was nominal and not adjusted.",
                            "statisticalMethod": "ANCOVA",
                            "paramType": "Mean Difference (Final Values)",
                            "paramValue": "2.47",
                            "ciPctValue": "95",
                            "ciNumSides": "TWO_SIDED",
                            "ciLowerLimit": "0.63",
                            "ciUpperLimit": "4.31",
                            "dispersionType": "STANDARD_ERROR_OF_MEAN",
                            "dispersionValue": "0.936",
                            "estimateComment": "The mean difference is actually adjusted mean of difference and the dispersion value is standard error of differences."
                        }
                    ]
                }
            ]
        },
        "adverseEventsModule": {
            "frequencyThreshold": "5",
            "timeFrame": "From the first dose of study medication until 7 days after last administration of BI 409306, up to 16 weeks.",
            "description": "The treated set (TS) used (all patients who were randomised and treated with at least one dose of trial medication.) for safety assessment.",
            "eventGroups": [
                {
                    "id": "EG000",
                    "title": "BI 409306 10 Milligram (mg) Once Daily (QD)",
                    "description": "Patients were administered orally a tablet of 10 mg BI 409306 once daily for 12 weeks.",
                    "deathsNumAffected": 1,
                    "deathsNumAtRisk": 55,
                    "seriousNumAffected": 1,
                    "seriousNumAtRisk": 55,
                    "otherNumAffected": 6,
                    "otherNumAtRisk": 55
                },
                {
                    "id": "EG001",
                    "title": "BI 409306 25 mg QD",
                    "description": "Patients were administered orally a tablet of 25 mg BI 409306 once daily for 12 weeks.",
                    "deathsNumAffected": 0,
                    "deathsNumAtRisk": 53,
                    "seriousNumAffected": 3,
                    "seriousNumAtRisk": 53,
                    "otherNumAffected": 9,
                    "otherNumAtRisk": 53
                },
                {
                    "id": "EG002",
                    "title": "BI 409306 50 mg QD",
                    "description": "Patients were administered orally a tablet of 50 mg BI 409306 once daily for 12 weeks.",
                    "deathsNumAffected": 0,
                    "deathsNumAtRisk": 55,
                    "seriousNumAffected": 1,
                    "seriousNumAtRisk": 55,
                    "otherNumAffected": 7,
                    "otherNumAtRisk": 55
                },
                {
                    "id": "EG003",
                    "title": "BI 409306 25 mg Twice Daily (BID)",
                    "description": "Patients were administered orally a tablet of 25 mg BI 409306 twice daily for 12 weeks.",
                    "deathsNumAffected": 0,
                    "deathsNumAtRisk": 55,
                    "seriousNumAffected": 3,
                    "seriousNumAtRisk": 55,
                    "otherNumAffected": 2,
                    "otherNumAtRisk": 55
                },
                {
                    "id": "EG004",
                    "title": "Placebo Matching BI 409306",
                    "description": "Patients were administered orally tablet of Placebo matching BI 409306 once daily for 12 weeks.",
                    "deathsNumAffected": 0,
                    "deathsNumAtRisk": 106,
                    "seriousNumAffected": 8,
                    "seriousNumAtRisk": 106,
                    "otherNumAffected": 8,
                    "otherNumAtRisk": 106
                },
                {
                    "id": "EG005",
                    "title": "Donepezil QD",
                    "description": "Patients were administered orally over capsulated tablet of Donepezil once daily for 12 weeks.",
                    "deathsNumAffected": 0,
                    "deathsNumAtRisk": 5,
                    "seriousNumAffected": 0,
                    "seriousNumAtRisk": 5,
                    "otherNumAffected": 1,
                    "otherNumAtRisk": 5
                }
            ],
            "seriousEvents": [
                {
                    "term": "Angina pectoris",
                    "organSystem": "Cardiac disorders",
                    "sourceVocabulary": "MedDRA 20.1",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 55
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 1,
                            "numAtRisk": 53
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 0,
                            "numAtRisk": 55
                        },
                        {
                            "groupId": "EG003",
                            "numAffected": 0,
                            "numAtRisk": 55
                        },
                        {
                            "groupId": "EG004",
                            "numAffected": 0,
                            "numAtRisk": 106
                        },
                        {
                            "groupId": "EG005",
                            "numAffected": 0,
                            "numAtRisk": 5
                        }
                    ]
                },
                {
                    "term": "Vertigo positional",
                    "organSystem": "Ear and labyrinth disorders",
                    "sourceVocabulary": "MedDRA 20.1",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 55
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 53
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 0,
                            "numAtRisk": 55
                        },
                        {
                            "groupId": "EG003",
                            "numAffected": 1,
                            "numAtRisk": 55
                        },
                        {
                            "groupId": "EG004",
                            "numAffected": 0,
                            "numAtRisk": 106
                        },
                        {
                            "groupId": "EG005",
                            "numAffected": 0,
                            "numAtRisk": 5
                        }
                    ]
                },
                {
                    "term": "Haemorrhoids",
                    "organSystem": "Gastrointestinal disorders",
                    "sourceVocabulary": "MedDRA 20.1",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 55
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 53
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 0,
                            "numAtRisk": 55
                        },
                        {
                            "groupId": "EG003",
                            "numAffected": 0,
                            "numAtRisk": 55
                        },
                        {
                            "groupId": "EG004",
                            "numAffected": 1,
                            "numAtRisk": 106
                        },
                        {
                            "groupId": "EG005",
                            "numAffected": 0,
                            "numAtRisk": 5
                        }
                    ]
                },
                {
                    "term": "Respiratory tract infection viral",
                    "organSystem": "Infections and infestations",
                    "sourceVocabulary": "MedDRA 20.1",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 55
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 53
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 0,
                            "numAtRisk": 55
                        },
                        {
                            "groupId": "EG003",
                            "numAffected": 0,
                            "numAtRisk": 55
                        },
                        {
                            "groupId": "EG004",
                            "numAffected": 1,
                            "numAtRisk": 106
                        },
                        {
                            "groupId": "EG005",
                            "numAffected": 0,
                            "numAtRisk": 5
                        }
                    ]
                },
                {
                    "term": "Craniocerebral injury",
                    "organSystem": "Injury, poisoning and procedural complications",
                    "sourceVocabulary": "MedDRA 20.1",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 55
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 53
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 0,
                            "numAtRisk": 55
                        },
                        {
                            "groupId": "EG003",
                            "numAffected": 0,
                            "numAtRisk": 55
                        },
                        {
                            "groupId": "EG004",
                            "numAffected": 1,
                            "numAtRisk": 106
                        },
                        {
                            "groupId": "EG005",
                            "numAffected": 0,
                            "numAtRisk": 5
                        }
                    ]
                },
                {
                    "term": "Fall",
                    "organSystem": "Injury, poisoning and procedural complications",
                    "sourceVocabulary": "MedDRA 20.1",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 55
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 53
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 0,
                            "numAtRisk": 55
                        },
                        {
                            "groupId": "EG003",
                            "numAffected": 0,
                            "numAtRisk": 55
                        },
                        {
                            "groupId": "EG004",
                            "numAffected": 1,
                            "numAtRisk": 106
                        },
                        {
                            "groupId": "EG005",
                            "numAffected": 0,
                            "numAtRisk": 5
                        }
                    ]
                },
                {
                    "term": "Electrocardiogram QT prolonged",
                    "organSystem": "Investigations",
                    "sourceVocabulary": "MedDRA 20.1",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 55
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 53
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 1,
                            "numAtRisk": 55
                        },
                        {
                            "groupId": "EG003",
                            "numAffected": 0,
                            "numAtRisk": 55
                        },
                        {
                            "groupId": "EG004",
                            "numAffected": 0,
                            "numAtRisk": 106
                        },
                        {
                            "groupId": "EG005",
                            "numAffected": 0,
                            "numAtRisk": 5
                        }
                    ]
                },
                {
                    "term": "Cerebrovascular accident",
                    "organSystem": "Nervous system disorders",
                    "sourceVocabulary": "MedDRA 20.1",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 55
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 1,
                            "numAtRisk": 53
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 0,
                            "numAtRisk": 55
                        },
                        {
                            "groupId": "EG003",
                            "numAffected": 0,
                            "numAtRisk": 55
                        },
                        {
                            "groupId": "EG004",
                            "numAffected": 0,
                            "numAtRisk": 106
                        },
                        {
                            "groupId": "EG005",
                            "numAffected": 0,
                            "numAtRisk": 5
                        }
                    ]
                },
                {
                    "term": "Dementia Alzheimer's type",
                    "organSystem": "Nervous system disorders",
                    "sourceVocabulary": "MedDRA 20.1",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 1,
                            "numAtRisk": 55
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 53
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 0,
                            "numAtRisk": 55
                        },
                        {
                            "groupId": "EG003",
                            "numAffected": 0,
                            "numAtRisk": 55
                        },
                        {
                            "groupId": "EG004",
                            "numAffected": 0,
                            "numAtRisk": 106
                        },
                        {
                            "groupId": "EG005",
                            "numAffected": 0,
                            "numAtRisk": 5
                        }
                    ]
                },
                {
                    "term": "Encephalopathy",
                    "organSystem": "Nervous system disorders",
                    "sourceVocabulary": "MedDRA 20.1",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 1,
                            "numAtRisk": 55
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 53
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 0,
                            "numAtRisk": 55
                        },
                        {
                            "groupId": "EG003",
                            "numAffected": 0,
                            "numAtRisk": 55
                        },
                        {
                            "groupId": "EG004",
                            "numAffected": 0,
                            "numAtRisk": 106
                        },
                        {
                            "groupId": "EG005",
                            "numAffected": 0,
                            "numAtRisk": 5
                        }
                    ]
                },
                {
                    "term": "Epilepsy",
                    "organSystem": "Nervous system disorders",
                    "sourceVocabulary": "MedDRA 20.1",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 55
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 53
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 0,
                            "numAtRisk": 55
                        },
                        {
                            "groupId": "EG003",
                            "numAffected": 0,
                            "numAtRisk": 55
                        },
                        {
                            "groupId": "EG004",
                            "numAffected": 1,
                            "numAtRisk": 106
                        },
                        {
                            "groupId": "EG005",
                            "numAffected": 0,
                            "numAtRisk": 5
                        }
                    ]
                },
                {
                    "term": "Loss of consciousness",
                    "organSystem": "Nervous system disorders",
                    "sourceVocabulary": "MedDRA 20.1",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 55
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 53
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 0,
                            "numAtRisk": 55
                        },
                        {
                            "groupId": "EG003",
                            "numAffected": 0,
                            "numAtRisk": 55
                        },
                        {
                            "groupId": "EG004",
                            "numAffected": 1,
                            "numAtRisk": 106
                        },
                        {
                            "groupId": "EG005",
                            "numAffected": 0,
                            "numAtRisk": 5
                        }
                    ]
                },
                {
                    "term": "Delirium",
                    "organSystem": "Psychiatric disorders",
                    "sourceVocabulary": "MedDRA 20.1",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 55
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 1,
                            "numAtRisk": 53
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 0,
                            "numAtRisk": 55
                        },
                        {
                            "groupId": "EG003",
                            "numAffected": 0,
                            "numAtRisk": 55
                        },
                        {
                            "groupId": "EG004",
                            "numAffected": 0,
                            "numAtRisk": 106
                        },
                        {
                            "groupId": "EG005",
                            "numAffected": 0,
                            "numAtRisk": 5
                        }
                    ]
                },
                {
                    "term": "Suicidal ideation",
                    "organSystem": "Psychiatric disorders",
                    "sourceVocabulary": "MedDRA 20.1",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 55
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 53
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 0,
                            "numAtRisk": 55
                        },
                        {
                            "groupId": "EG003",
                            "numAffected": 2,
                            "numAtRisk": 55
                        },
                        {
                            "groupId": "EG004",
                            "numAffected": 1,
                            "numAtRisk": 106
                        },
                        {
                            "groupId": "EG005",
                            "numAffected": 0,
                            "numAtRisk": 5
                        }
                    ]
                },
                {
                    "term": "Nephrolithiasis",
                    "organSystem": "Renal and urinary disorders",
                    "sourceVocabulary": "MedDRA 20.1",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 55
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 53
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 0,
                            "numAtRisk": 55
                        },
                        {
                            "groupId": "EG003",
                            "numAffected": 1,
                            "numAtRisk": 55
                        },
                        {
                            "groupId": "EG004",
                            "numAffected": 0,
                            "numAtRisk": 106
                        },
                        {
                            "groupId": "EG005",
                            "numAffected": 0,
                            "numAtRisk": 5
                        }
                    ]
                },
                {
                    "term": "Pulmonary embolism",
                    "organSystem": "Respiratory, thoracic and mediastinal disorders",
                    "sourceVocabulary": "MedDRA 20.1",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 55
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 53
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 0,
                            "numAtRisk": 55
                        },
                        {
                            "groupId": "EG003",
                            "numAffected": 0,
                            "numAtRisk": 55
                        },
                        {
                            "groupId": "EG004",
                            "numAffected": 1,
                            "numAtRisk": 106
                        },
                        {
                            "groupId": "EG005",
                            "numAffected": 0,
                            "numAtRisk": 5
                        }
                    ]
                },
                {
                    "term": "Deep vein thrombosis",
                    "organSystem": "Vascular disorders",
                    "sourceVocabulary": "MedDRA 20.1",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 55
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 53
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 0,
                            "numAtRisk": 55
                        },
                        {
                            "groupId": "EG003",
                            "numAffected": 0,
                            "numAtRisk": 55
                        },
                        {
                            "groupId": "EG004",
                            "numAffected": 1,
                            "numAtRisk": 106
                        },
                        {
                            "groupId": "EG005",
                            "numAffected": 0,
                            "numAtRisk": 5
                        }
                    ]
                },
                {
                    "term": "Peripheral artery aneurysm",
                    "organSystem": "Vascular disorders",
                    "sourceVocabulary": "MedDRA 20.1",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 55
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 53
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 0,
                            "numAtRisk": 55
                        },
                        {
                            "groupId": "EG003",
                            "numAffected": 0,
                            "numAtRisk": 55
                        },
                        {
                            "groupId": "EG004",
                            "numAffected": 1,
                            "numAtRisk": 106
                        },
                        {
                            "groupId": "EG005",
                            "numAffected": 0,
                            "numAtRisk": 5
                        }
                    ]
                }
            ],
            "otherEvents": [
                {
                    "term": "Nasopharyngitis",
                    "organSystem": "Infections and infestations",
                    "sourceVocabulary": "MedDRA 20.1",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 1,
                            "numAtRisk": 55
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 4,
                            "numAtRisk": 53
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 3,
                            "numAtRisk": 55
                        },
                        {
                            "groupId": "EG003",
                            "numAffected": 0,
                            "numAtRisk": 55
                        },
                        {
                            "groupId": "EG004",
                            "numAffected": 1,
                            "numAtRisk": 106
                        },
                        {
                            "groupId": "EG005",
                            "numAffected": 0,
                            "numAtRisk": 5
                        }
                    ]
                },
                {
                    "term": "Back pain",
                    "organSystem": "Musculoskeletal and connective tissue disorders",
                    "sourceVocabulary": "MedDRA 20.1",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 3,
                            "numAtRisk": 55
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 53
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 0,
                            "numAtRisk": 55
                        },
                        {
                            "groupId": "EG003",
                            "numAffected": 1,
                            "numAtRisk": 55
                        },
                        {
                            "groupId": "EG004",
                            "numAffected": 2,
                            "numAtRisk": 106
                        },
                        {
                            "groupId": "EG005",
                            "numAffected": 0,
                            "numAtRisk": 5
                        }
                    ]
                },
                {
                    "term": "Headache",
                    "organSystem": "Nervous system disorders",
                    "sourceVocabulary": "MedDRA 20.1",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 2,
                            "numAtRisk": 55
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 5,
                            "numAtRisk": 53
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 1,
                            "numAtRisk": 55
                        },
                        {
                            "groupId": "EG003",
                            "numAffected": 1,
                            "numAtRisk": 55
                        },
                        {
                            "groupId": "EG004",
                            "numAffected": 5,
                            "numAtRisk": 106
                        },
                        {
                            "groupId": "EG005",
                            "numAffected": 0,
                            "numAtRisk": 5
                        }
                    ]
                },
                {
                    "term": "Cough",
                    "organSystem": "Respiratory, thoracic and mediastinal disorders",
                    "sourceVocabulary": "MedDRA 20.1",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 55
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 53
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 3,
                            "numAtRisk": 55
                        },
                        {
                            "groupId": "EG003",
                            "numAffected": 0,
                            "numAtRisk": 55
                        },
                        {
                            "groupId": "EG004",
                            "numAffected": 0,
                            "numAtRisk": 106
                        },
                        {
                            "groupId": "EG005",
                            "numAffected": 0,
                            "numAtRisk": 5
                        }
                    ]
                },
                {
                    "term": "Rhinitis allergic",
                    "organSystem": "Respiratory, thoracic and mediastinal disorders",
                    "sourceVocabulary": "MedDRA 20.1",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numAffected": 0,
                            "numAtRisk": 55
                        },
                        {
                            "groupId": "EG001",
                            "numAffected": 0,
                            "numAtRisk": 53
                        },
                        {
                            "groupId": "EG002",
                            "numAffected": 0,
                            "numAtRisk": 55
                        },
                        {
                            "groupId": "EG003",
                            "numAffected": 0,
                            "numAtRisk": 55
                        },
                        {
                            "groupId": "EG004",
                            "numAffected": 0,
                            "numAtRisk": 106
                        },
                        {
                            "groupId": "EG005",
                            "numAffected": 1,
                            "numAtRisk": 5
                        }
                    ]
                }
            ]
        },
        "moreInfoModule": {
            "limitationsAndCaveats": {
                "description": "There were 5 patients who were randomised to donepezil arm which was dropped from the trial with protocol amendment. No further patients were randomised to this arm, but patients already randomised continued in the trial as originally planned."
            },
            "certainAgreement": {
                "piSponsorEmployee": false,
                "restrictionType": "OTHER",
                "restrictiveAgreement": true,
                "otherDetails": "Boehringer Ingelheim (BI) acknowledges that investigators have the right to publish the study results. Investigators shall provide BI with a copy of any publication or presentation for review prior to any submission. Such review will be done with regard to proprietary information, information related to patentable inventions, medical, scientific, and statistical accuracy within 60 days. BI may request a delay of the publication in order to protect BI's intellectual property rights."
            },
            "pointOfContact": {
                "title": "Boehringer Ingelheim, Call Centre",
                "organization": "Boehringer Ingelheim",
                "email": "clintriage.rdg@boehringer-ingelheim.com",
                "phone": "1-800-243-0127"
            }
        }
    },
    "target_category": "cognitive enhancer",
    "drug": [
        "BI 409306 (oral small-molecule phosphodiesterase 9A [PDE9A] inhibitor; intended as a symptomatic cognitive treatment)"
    ],
    "placebo": [
        "placebo"
    ],
    "explanation_target": [
        "Reason: The trial tests BI 409306, an orally administered small molecule that selectively inhibits phosphodiesterase 9A (PDE9A). PDE9A inhibition raises cGMP with the goal of improving synaptic signalling and cognition rather than directly removing amyloid or tau pathology, so the mechanism and intended effect are symptomatic cognitive enhancement. \ue200cite\ue202turn0search0\ue202turn0search1\ue201",
        "Act: Key trial details \u2014 multicentre, double-blind, parallel-group RCT of oral BI 409306 vs placebo for 12 weeks in patients with cognitive impairment due to Alzheimer\u2019s disease; primary endpoints were cognitive measures (e.g., Neuropsychological Test Battery). BI 409306 is described in the literature and clinicaltrials reports as a PDE9A inhibitor developed for cognitive improvement. \ue200cite\ue202turn0search1\ue202turn0search2\ue201",
        "Additional supporting evidence: Phase I/II publications describe BI 409306 as a potent, selective PDE9A inhibitor that increases CSF cGMP and was tested for cognitive outcomes in AD and schizophrenia. The pooled phase II analysis reported no cognitive benefit over placebo, though the compound was generally well tolerated. \ue200cite\ue202turn0search0\ue202turn0search2\ue202turn0search5\ue201",
        "Reflect: Classification rationale \u2014 This is not a biologic (no monoclonal antibody or vaccine) and does not target core AD pathology (amyloid or tau) directly, so it does not meet the definitions for 'disease-targeted biologic' or 'disease-targeted small molecule.' Instead it is a small-molecule, symptomatic cognitive enhancer acting via PDE9A inhibition; therefore 'cognitive enhancer' is the appropriate category. No significant ambiguity remains given the clear mechanism and trial endpoints. \ue200cite\ue202turn0search2\ue202turn0search1\ue201"
    ],
    "agent_type": "M) Synaptic Plasticity/Neuroprotection",
    "explanation_agent": [
        "Reason: BI 409306 is an oral small-molecule inhibitor of phosphodiesterase 9A (PDE9A) that raises cGMP and is intended to strengthen NMDA receptor\u2013related signalling, long-term potentiation and synaptic plasticity to improve cognition (a symptomatic cognitive-enhancer mechanism rather than direct anti-amyloid or anti-tau disease modification). \ue200cite\ue202turn0search4\ue202turn0search2\ue201",
        "Act: Key trial details and drug mechanism \u2014 multicentre, double-blind, parallel-group RCTs of BI 409306 (10\u201350 mg daily for 12 weeks) in prodromal/mild AD used cognitive batteries (NTB, CDR-SB, ADAS-Cog) as primary/secondary endpoints; BI 409306 is described in the literature and phase I studies as a selective PDE9A inhibitor that increases CSF cGMP. These facts point to a synaptic-plasticity / neuroprotection symptomatic strategy rather than amyloid/tau, inflammation, or vascular targeting. \ue200cite\ue202turn0search1\ue202turn0search2\ue201",
        "Reflect: The mechanism (PDE9A inhibition \u2192 increased cGMP \u2192 enhanced LTP/synaptic signalling) maps directly to CADRO category M (Synaptic Plasticity/Neuroprotection). The trial targets symptomatic cognitive enhancement through synaptic function, with no evidence of amyloid-, tau-, ApoE- or inflammation-directed disease modification; therefore M is the most specific fit. \ue200cite\ue202turn0search4\ue201",
        "Web search results used (selected):",
        "- Phase II pooled analyses and full-text description of the two phase II RCTs in prodromal and mild AD (BI 409306; cognitive endpoints; no clinical benefit observed). \ue200cite\ue202turn0search1\ue202turn0search4\ue201",
        "- Phase I proof-of-mechanism study showing BI 409306 increases CSF cGMP (pharmacodynamic evidence supporting synaptic/cGMP mechanism). \ue200cite\ue202turn0search2\ue201",
        "- Phase II trial in schizophrenia describing BI 409306 as a selective PDE9 inhibitor and reporting cognitive outcome data and safety. \ue200cite\ue202turn0search0\ue201"
    ]
}